TFAP2A and gastric cancer: All in a word, our datas have revealed that EGCG inhibits GC growth and reversal of fluorouracil resistance of gastric cancer cells through inactivation of TFAP2A/VEGF signaling pathway and down-regulation of MDR-1 and P-gp expression.